COPD: Pharmacist Guidance Improves Patient Outcomes – Study
- A quality betterment study published in Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation reveals that targeted guidance from pharmacists significantly improves how patients with chronic obstructive...
- Researchers at the Queen Elisabeth Institute, a pulmonary rehabilitation hospital, implemented a program where pharmacists provided intensive, step-by-step instruction to patients.
- Annelies Walravens explained that the idea stemmed from observing patients struggling with inhaler usage.
Pharmacist-led programs dramatically improve outcomes for Chronic Obstructive Pulmonary Disease (COPD) patients. A new study confirms that intensive,step-by-step guidance from pharmacists significantly enhances inhaler technique and boosts patient empowerment.Researchers at the Queen Elisabeth Institute observed marked improvements in patients receiving personalized instruction,highlighting the impact of pharmacist involvement in COPD management. The study, which adapted successful community pharmacy models, demonstrates a clear path to better medication adherence. Doctors, nurses, and IT staff acknowledge the value of this multidisciplinary approach. News Directory 3 reports this significant advancement in patient care. Discover how this research offers a solid foundation for structured improvement in hospitals.Discover what’s next …
Pharmacist Program Boosts COPD Inhaler use, Study Finds
A quality betterment study published in Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation reveals that targeted guidance from pharmacists significantly improves how patients with chronic obstructive pulmonary disease (COPD) use their inhalers.
Researchers at the Queen Elisabeth Institute, a pulmonary rehabilitation hospital, implemented a program where pharmacists provided intensive, step-by-step instruction to patients. The results showed marked improvement in inhaler technique and increased patient empowerment.
Annelies Walravens explained that the idea stemmed from observing patients struggling with inhaler usage. The study demonstrated the positive impact of personalized instruction from a pharmacist.
Emma Walravens noted that the program adapted a model of pharmaceutical counseling previously studied in community pharmacies by Prof. Eline Tommelein.The study involved following each patient six times during their hospital stay and in the weeks following discharge.
Stephanie Wuyts, from VUB’s Research Center for Digital Medicine, emphasized that many patients were receiving such detailed medication explanations for the first time. The personal attention greatly improved their adherence to treatment.
Sander Boudewyn, of the Queen Elisabeth Institute, reported that doctors, nurses, IT staff, and other professionals acknowledged the protocol’s value. They considered it a realistic and beneficial addition to patient care.
Kayleigh Spriet,also from the Queen Elisabeth Institute,highlighted that proper task distribution and IT support enable pharmacists to concentrate on education and follow-up,maximizing their impact.
Pulmonologist Dr. Kristel De Paepe stated that the project’s strength lies in multidisciplinary collaboration, with pharmacists playing a central role in enhancing patient care.
Prof. Tommelein (VUB) concluded that the research provides a solid foundation for a structured approach within hospitals to improve medication adherence and,consequently,patients’ quality of life.The pilot project now offers tools for structural improvement.
More information: Annelies I.M. walravens et al, Inhalation Innovation: Optimizing COPD Care Through Clinical Pharmacist Integration in a Rehabilitation Hospital’s Multidisciplinary Team—A Quality Improvement Study, Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation (2025). DOI: 10.15326/jcopdf.2024.0569